Elisa Mansfield, Vice President, FSP at Phastar, contributed an article for the October issue of Applied Clinical Trials titled ‘Implementing a Gold Standard FSP Strategic Partnership’.
The article discusses how biotech and biopharma companies can make sure they choose the right FSP solution to maximize financial efficiency, quality, operational effectiveness, and overall success.
‘In a new era of outsourcing, working with an FSP is no longer just about contributing to technical projects as a team or individual. Instead, FSPs are supporting sponsors through strategic oversight and by leveraging business operations data to sustain clinical development and reporting.’